PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
Cash Flow Under PressureContracting
Percentile Rank75
3Y CAGR+5.2%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+5.2%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$8.92B-11.2%
2024$10.05B+107.6%
2023$4.84B-36.9%
2022$7.66B+2107.4%
2021$347.20M-